TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...
Clinical Trials Arena on MSN
QurAlis announces Phase I QRL-101 trial topline results in ALS
Kv7.2/7.3 channels are voltage-gated potassium channels involved in regulating membrane potential and neuronal excitability.
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...
Health and Me on MSN
Can Alzheimer’s disease be reversed? Here’s what the new research shows
New US research suggests Alzheimer’s disease may be reversible in animal studies. Scientists found restoring NAD levels improved brain function and cognition, raising hope for future treatments. Keep ...
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...
Researchers from Kyushu University have developed an innovative computational method, called ddHodge, that can reconstruct ...
What scientists long believed were knots in DNA may actually be persistent twists formed during nanopore analysis, revealing ...
This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback